The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc | COM | 00289Y107 | 10,029 | 626,804 | SH | SOLE | 626,804 | 0 | 0 | ||
Acorda Therapeutics Inc | COM | 00484M106 | 4,259 | 148,380 | SH | SOLE | 148,380 | 0 | 0 | ||
Allergan PLC | SHS | G0177J108 | 37,031 | 222,113 | SH | SOLE | 222,113 | 0 | 0 | ||
Akorn Inc | COM | 009728106 | 4,471 | 269,503 | SH | SOLE | 269,503 | 0 | 0 | ||
Alexion Pharmaceuticals Inc | COM | 015351109 | 16,465 | 132,623 | SH | SOLE | 132,623 | 0 | 0 | ||
Aerpio Pharmaceuticals Inc | COM | 00810B105 | 1,240 | 298,873 | SH | SOLE | 298,873 | 0 | 0 | ||
Avrobio Inc | COM | 05455M100 | 286 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
AstraZeneca PLC | SPONSORED ADR | 046353108 | 18,267 | 520,279 | SH | SOLE | 520,279 | 0 | 0 | ||
BioMarin Pharmaceutical Inc | COM | 09061G101 | 28,260 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
Audentes Therapeutics Inc | COM | 05070R104 | 9,228 | 241,500 | SH | SOLE | 241,500 | 0 | 0 | ||
Cara Therapeutics Inc | COM | 140755109 | 8,346 | 435,800 | SH | SOLE | 435,800 | 0 | 0 | ||
Cymabay Therapeutics Inc | COM | 23257D103 | 11,121 | 828,655 | SH | SOLE | 828,655 | 0 | 0 | ||
Catalyst Biosciences Inc | COM NEW | 14888D208 | 9,183 | 786,865 | SH | SOLE | 786,865 | 0 | 0 | ||
Cellectis SA | SPONSORED ADS | 15117K103 | 15,509 | 548,212 | SH | SOLE | 548,212 | 0 | 0 | ||
Corcept Therapeutics Inc | COM | 218352102 | 5,269 | 335,177 | SH | SOLE | 335,177 | 0 | 0 | ||
Corbus Pharmaceuticals Holding | COM | 21833P103 | 678 | 134,280 | SH | SOLE | 134,280 | 0 | 0 | ||
Deciphera Pharmaceuticals Inc | COM | 24344T101 | 5,108 | 129,800 | SH | SOLE | 129,800 | 0 | 0 | ||
Dova Pharmaceuticals Inc | COM | 25985T102 | 24,545 | 820,348 | SH | SOLE | 820,348 | 0 | 0 | ||
Endocyte Inc | COM | 29269A102 | 8,225 | 596,000 | SH | SOLE | 596,000 | 0 | 0 | ||
Esperion Therapeutics Inc | COM | 29664W105 | 11,259 | 287,300 | SH | SOLE | 287,300 | 0 | 0 | ||
Exelixis Inc | COM | 30161Q104 | 30,593 | 1,421,600 | SH | SOLE | 1,421,600 | 0 | 0 | ||
FibroGen Inc | COM | 31572Q808 | 8,487 | 135,583 | SH | SOLE | 135,583 | 0 | 0 | ||
Global Blood Therapeutics Inc | COM | 37890U108 | 18,265 | 404,092 | SH | SOLE | 404,092 | 0 | 0 | ||
Immunomedics Inc | COM | 452907108 | 31,460 | 1,329,104 | SH | SOLE | 1,329,104 | 0 | 0 | ||
Insmed Inc | COM PAR $.01 | 457669307 | 15,298 | 646,863 | SH | SOLE | 646,863 | 0 | 0 | ||
Kiniksa Pharmaceuticals Ltd | COM CL A | G5269C101 | 680 | 39,180 | SH | SOLE | 39,180 | 0 | 0 | ||
Kura Oncology Inc | COM | 50127T109 | 6,943 | 381,459 | SH | SOLE | 381,459 | 0 | 0 | ||
MediWound Ltd | ORD SHS | M68830104 | 308 | 44,576 | SH | SOLE | 44,576 | 0 | 0 | ||
Magenta Therapeutics Inc | COM | 55910K108 | 2,025 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Molecular Templates Inc | COM | 608550109 | 902 | 172,384 | SH | SOLE | 172,384 | 0 | 0 | ||
Mylan NV | SHS EURO | N59465109 | 15,613 | 432,009 | SH | SOLE | 432,009 | 0 | 0 | ||
Neos Therapeutics Inc | COM | 64052L106 | 2,369 | 378,961 | SH | SOLE | 378,961 | 0 | 0 | ||
OncoSec Medical Inc | COM NEW | 68234L207 | 3,608 | 2,614,297 | SH | SOLE | 2,614,297 | 0 | 0 | ||
Pacira Pharmaceuticals Inc/DE | COM | 695127100 | 18,157 | 566,508 | SH | SOLE | 566,508 | 0 | 0 | ||
Sage Therapeutics Inc | COM | 78667J108 | 12,378 | 79,080 | SH | SOLE | 79,080 | 0 | 0 | ||
Seattle Genetics Inc | COM | 812578102 | 6,784 | 102,187 | SH | SOLE | 102,187 | 0 | 0 | ||
Sangamo Therapeutics Inc | COM | 800677106 | 15,150 | 1,066,914 | SH | SOLE | 1,066,914 | 0 | 0 | ||
Sol-Gel Technologies Ltd | SHS | M8694L103 | 3,979 | 515,373 | SH | SOLE | 515,373 | 0 | 0 | ||
Stemline Therapeutics Inc | COM | 85858C107 | 8,980 | 559,517 | SH | SOLE | 559,517 | 0 | 0 | ||
TG Therapeutics Inc | COM | 88322Q108 | 949 | 72,200 | SH | SOLE | 72,200 | 0 | 0 | ||
TG Therapeutics Inc | COM | 88322Q108 | 658 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
TESARO Inc | COM | 881569107 | 19,278 | 433,500 | SH | SOLE | 433,500 | 0 | 0 | ||
Versartis Inc | COM | 92529L102 | 1,013 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P BIOTECH | 78464A870 | 190,380 | 2,000,000 | SH | Put | SOLE | 2,000,000 | 0 | 0 | |
Zosano Pharma Corp | COM NEW | 98979H202 | 2,856 | 700,000 | SH | SOLE | 700,000 | 0 | 0 |